Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
Status:
Active, not recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Randomized open-label multicenter parallel-group study of efficacy and safety of TL-FVP-t vs.
standard of care therapy in patients with mild to moderate coronavirus disease
(SARS-CoV-2/COVID-19)